Pharma Journalist - Page 673 of 831 -

Valneva Submits Label Extension Application for its Chikungunya Vaccine, IXCHIQ, to the U.S. FDA

Acadia Pharmaceuticals Announces Exclusive License Agreement with Saniona for SAN711

Roche enters into a definitive agreement to acquire Poseida Therapeutics, including cell therapy candidates and related platform technologies

DEFINE FLAIR Clinical trial signals Philip’s iFR more cost-friendly than FFR

Abbott’s HeartMate 3 Heart Pump displays enhanced survival and lower rates of Stroke and Pump Thrombosis

Janssen Pharmaceutical’s INVOKANA alleviates risk of CV death or HHF in type 2 diabetes patients

Novartis expands alliance with Science 37 to advance virtual clinical trials program

Tango Therapeutics enhances board of directors adding Oncology Experts

Eyenuk receives Health Canada approval for EyeArt

TherapeuticsMD concedes FDA acceptance of NDA and PDUFA date for TX-001HR

InVivo Therapeutics receives FDA approval for trial of Neuro-Spinal Scaffold

Tyber Medical asserts the launch of TyFix

Ortho Clinical Diagnostics institutes VITROS C-peptide Assay